GT Biopharma, Inc.
New Filing
CIK: 0000109657·Biotechnology·FLORIDA·Filed: Feb 6, 2018
Total Offering
$7,055,000
Amount Sold
$7,055,000
Investors
14
First Sale
Jan 23, 2018
Offering Details
- Type
- Debt, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Steven Weldon | Related Person |
| Anthony J. Cataldo | Related Person |
| Kathleen Clarence-Smith | Related Person |
| Geoffrey B. Davis | Related Person |
Company
SEC Filing
0001654954-18-001133
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free